Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Luxfer to Report 2018 Fourth Quarter and Year-end Financial Results on March 11 and Host Conference Call on March 12
-
Carbon Black (CBLK) Appoints Vanessa Pegueros to Board
-
Illumina (ILMN) Announces Susan Siegel to Board
-
SeaWorld Entertainment (SEAS) Names Gustavo Antorcha as CEO
-
Gridsum (GSUM) Announces Herman Fong as Board Member and Co-President with Focus on Corporate Development
-
Insulet (PODD) Announces Corinne Nevinny to Board
-
NextEra Energy (NEE) reports organizational changes
-
NextEra Energy announces organizational changes
-
Adobe Systems (ADBE) Appoints Leeny Oberg and Dheeraj Pandey to Board
-
Dicerna Pharma (DRNA) announces elevation of J. Kevin Buchi to chairman
-
Intellia Therapeutics (NTLA) Appoints Fred Cohen M.D. to Board
-
Penumbra, Inc. (PEN) Announces Janet Leeds and Surbhi Sarna to Board
-
Omeros (OMER) Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy
-
Stanford Graduate School of Business Announces New Executive Education Program to Drive Innovation and Operational Excellence
-
Zosano Pharma (ZSAN) Announces Linda Grais M.D., J.D. to Board
-
Broadcom (AVGO) Announces Diane M. Bryant to Board
-
Torex Reports Record Production of 354,000 Ounces of Gold in 2018 and Provides 2019 Outlook
-
Cavco Industries (CVCO) Announces Susan L. Blount to Board
-
Luxfer Declares Quarterly Dividend
-
Senseonics Holdings (SENS) Announces Jon Isaacson as CFO
-
Wells Fargo (WFC) Appoints Wayne M. Hewett to Board
-
iRhythm Technologies (IRTC) Says Research Published in Nature Medicine Demonstrates Promise of Algorithm-Based Ambulatory Cardiac Monitoring
-
Ironwood Pharma (IRWD) Confirms Mark Mallon as New CEO
-
XOMA (XOMA) Names Barbara Kosacz to Board
-
Jazz Pharmaceuticals (JAZZ) Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness
-
Kodiak Sciences Inc. (KOD) Reports Completion of 12-Week Phase 1a Study of KSI-301
-
Synthorx Inc. (THOR) Announces Andrew Powell, J.D. to Board
-
Heartland Financial (HTLF) Appoints Jennifer K. Hopkins to Board
-
IMV Inc. (IMV) Reports Updated Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer
-
CF Industries (CF) Reports Election of Javed Ahmed to Board
-
Global IDTechEx Research on Emerging Applications for Electronic Skin Patches
-
BeyondSpring (BYSI) Reports Phase 3 Study 105, Evaluating Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
-
Stanford University Reports FY2018 Financial Results
-
Northrim BanCorp (NRIM) Announces Aaron M. Schutt to Board
-
A Healthier WE Announces Inaugural Healthier Rural West Summit
-
BioTime (BTX) Announces Publication of Positive Preclinical Results Utilizing Proprietary HyStem Platform in Ischemic Stroke
-
Sesen Bio (SESN) Appoints Dennis Kim, M.D., MPH, as CMO
-
Western Digital (WDC) Names Kimberly Alexy and Stephanie Streeter to Board
-
Jazz Pharmaceuticals (JAZZ) Reports First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for Treatment of Idiopathic Hypersomnia
-
Form 4 GLEN BURNIE BANCORP For: Oct 03 Filed by: Hess Stanford
-
Form 3 GLEN BURNIE BANCORP For: Aug 09 Filed by: Hess Stanford
-
Fed's Clarida Comments on Data Dependence and U.S. Monetary Policy
-
Rocket Pharmaceuticals (RCKT) Granted FDA Regenerative Medicine Advanced Therapy & Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia
-
Luxfer Holdings plc (LXFR) Names Richard Hipple to Board
-
Luxfer Announces Appointment of Richard Hipple to Board of Directors
-
Tenax Therapeutics (TENX) Reports Activation of First Clinical Research Site for Phase 2 Pulmonary Hypertension Clinical Trial
-
Stanford Neuroscientist Karl Deisseroth Receives Japan’s Kyoto Prize in Advanced Technology
-
CVS Health (CVS) Releases Statement on FDA Decision to Restrict Flavored Tobacco Products
-
ADT Corp. (ADT) Names Tracey Griffin to Board
-
Jazz Pharmaceuticals (JAZZ) Reports Submission of Marketing Authorization Application to European Medicines Agency for Solriamfetol

